Cell-context specific role of the E2F/Rb pathway in development and disease

GLIA

Volumn 58, Issue 4, 2010, Pages 377-390

  Swiss, Victoria A ^a,b   Casaccia, Patrizia ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Brain; Cell cycle; Differentiation; Glia; Proliferation; Tumor

Indexed keywords

CRE RECOMBINASE; CYCLIN DEPENDENT KINASE; PROTEIN P107; PROTEIN P130; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F;

APOPTOSIS; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL FATE; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; DNA BINDING; GENE MUTATION; GENOTYPE; GLIA; KNOCKOUT MOUSE; MOUSE; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; REVIEW; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

ANIMALS; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM DISEASES; E2F TRANSCRIPTION FACTORS; HUMANS; RETINOBLASTOMA PROTEIN; SIGNAL TRANSDUCTION;

EID: 76549105557     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.20933     Document Type: Review

References (176)

1. Ait-Si-Ali S, Guasconi V, Fritsch L, Yahi H, Sekhri R, Naguibneva I, Robin P, Cabon F, Polesskaya A, Harel-Bellan A. 2004. A Suv39h-dependent mechanism for silencing S-phase genes in differentiating but not in cycling cells. EMBO J 23:605-615.
2. Ajioka I, Martins RA, Bayazitov IT, Donovan S, Johnson DA, Frase S, Cicero SA, Boyd K, Zakharenko SS, Dyer MA. 2007. Differentiated horizontal interneurons clonally expand to form metastatic retinoblastoma in mice. Cell 131:378-390.
3. Alonso MM, Alemany R, Fueyo J, Gomez-Manzano C. 2008. E2F1 in gliomas: A paradigm of oncogene addiction. Cancer Lett 263:157-163.
4. Alonso MM, Cascallo M, Gomez-Manzano C, Jiang H, Bekele BN, Perez-Gimenez A, Lang FF, Piao Y, Alemany R, Fueyo J. 2007. ICOVIR-5 shows E2F1 addiction and potent antiglioma effect in vivo. Cancer Res 67:8255-8263.
5. Bagchi S, Weinmann R, Raychaudhuri P. 1991. The retinoblastoma protein copurifies with E2F-I, an E1A-regulated inhibitor of the transcription factor E2F. Cell 65:1063-1072.
6. Bandara LR, Adamczewski JP, Hunt T, La Thangue NB. 1991. Cyclin A and the retinoblastoma gene product complex with a common transcription factor. Nature 352:249-251.
7. Bandara LR, Buck VM, Zamanian M, Johnston LH, La Thangue NB. 1993. Functional synergy between DP-1 and E2F-1 in the cell cycle-regulating transcription factor DRTF1/E2F. EMBO J 12:4317-4324.
8. Beijersbergen RL, Kerkhoven RM, Zhu L, Carlee L, Voorhoeve PM, Bernards R. 1994. E2F-4, a new member of the E2F gene family, has oncogenic activity and associates with p107 in vivo. Genes Dev 8:2680-2690.
9. Bieda M, Xu X, Singer MA, Green R, Farnham PJ. 2006. Unbiased location analysis of E2F1-binding sites suggests a widespread role for E2F1 in the human genome. Genome Res 16:595-605.
10. Blais A, Dynlacht BD. 2004. Hitting their targets: An emerging picture of E2F and cell cycle control. Curr Opin Genet Dev 14:527-532.
11. Blais A, Dynlacht BD. 2007. E2F-associated chromatin modifiers and cell cycle control. Curr Opin Cell Biol 19:658-662.
12. Brehm A, Miska EA, McCance DJ, Reid JL, Bannister AJ, Kouzarides T. 1998. Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 391:597-601.
13. Bruce JL, Hurford RK Jr, Classon M, Koh J, Dyson N. 2000. Requirements for cell cycle arrest by p16INK4a. Mol Cell 6:737-742.
14. Burns KA, Ayoub AE, Breunig JJ, Adhami F, Weng WL, Colbert MC, Rakic P, Kuan CY. 2007. Nestin-CreER mice reveal DNA synthesis by nonapoptotic neurons following cerebral ischemia hypoxia. Cereb Cortex 17:2585-2592.
15. Busser J, Geldmacher DS, Herrup K. 1998. Ectopic cell cycle proteins predict the sites of neuronal cell death in Alzheimer's disease brain. J Neurosci 18:2801-2807.
16. Callaghan DA, Dong L, Callaghan SM, Hou YX, Dagnino L, Slack RS. 1999. Neural precursor cells differentiating in the absence of Rb exhibit delayed terminal mitosis and deregulated E2F 1 and 3 activity. Dev Biol 207:257-270.
17. Caretti G, Salsi V, Vecchi C, Imbriano C, Mantovani R. 2003. Dynamic recruitment of NF-Y and histone acetyltransferases on cell-cycle promoters. J Biol Chem 278:30435-30440.
18. Chellappan SP, Hiebert S, Mudryj M, Horowitz JM, Nevins JR. 1991. The E2F transcription factor is a cellular target for the RB protein. Cell 65:1053-1061.
19. Chen D, Livne-Bar I, Vanderluit JL, Slack RS, Agochiya M, Bremner R. 2004. Cell-specific effects of RB or RB/p107 loss on retinal development implicate an intrinsically death-resistant cell-of-origin in retinoblastoma. Cancer Cell 5:539-551.
20. Chen D, Opavsky R, Pacal M, Tanimoto N, Wenzel P, Seeliger MW, Leone G, Bremner R. 2007. Rb-mediated neuronal differentiation through cell-cycle-independent regulation of E2f3a. PLoS Biol 5:e179.
21. Chittenden T, Livingston DM, Kaelin WG Jr. 1991. The T/E1A-binding domain of the retinoblastoma product can interact selectively with a sequence-specific DNA-binding protein. Cell 65:1073-1082.
22. Chong JL, Tsai SY, Sharma N, Opavsky R, Price R, Wu L, Fernandez SA, Leone G. 2009. E2f3a and E2f3b contribute to the control of cell proliferation and mouse development. Mol Cell Biol 29:414-424.
23. Christensen J, Cloos P, Toftegaard U, Klinkenberg D, Bracken AP, Trinh E, Heeran M, Di Stefano L, Helin K. 2005. Characterization of E2F8, a novel E2F-like cell-cycle regulated repressor of E2F-activated transcription. Nucleic Acids Res 33:5458-5470.
24. Clarke AR, Maandag ER, van Roon M, van der Lugt NM, van der Valk M, Hooper ML, Berns A, te Riele H. 1992. Requirement for a functional Rb-1 gene in murine development. Nature 359:328-330.
25. Cloud JE, Rogers C, Reza TL, Ziebold U, Stone JR, Picard MH, Caron AM, Bronson RT, Lees JA. 2002. Mutant mouse models reveal the relative roles of E2F1 and E2F3 in vivo. Mol Cell Biol 22:2663-2672.
26. Cobrinik D. 2005. Pocket proteins and cell cycle control. Oncogene 24:2796-2809.
27. Cobrinik D, Lee MH, Hannon G, Mulligan G, Bronson RT, Dyson N, Harlow E, Beach D, Weinberg RA, Jacks T. 1996. Shared role of the pRB-related p130 and p107 proteins in limb development. Genes Dev 10:1633-1644.
28. Cobrinik D, Whyte P, Peeper DS, Jacks T, Weinberg RA. 1993. Cell cycle-specific association of E2F with the p130 E1A-binding protein. Genes Dev A 7:2392-2404.
29. Cooper-Kuhn CM, Vroemen M, Brown J, Ye H, Thompson MA, Winkler J, Kuhn HG. 2002. Impaired adult neurogenesis in mice lacking the transcription factor E2F1. Mol Cell Neurosci 21:312-323.
30. Courel M, Friesenhahn L, Lees JA. 2008. E2f6 and Bmi1 cooperate in axial skeletal development. Dev Dyn 237:1232-1242.
31. Dagnino L, Fry CJ, Bartley SM, Farnham P, Gallie BL, Phillips RA. 1997. Expression patterns of the E2F family of transcription factors during mouse nervous system development. Mech Dev 66:13-25.
32. de Bruin A, Maiti B, Jakoi L, Timmers C, Buerki R, Leone G. 2003. Identification and characterization of E2F7, a novel mammalian E2F family member capable of blocking cellular proliferation. J Biol Chem 278:42041-42049.
33. DeGregori J, Johnson DG. 2006. Distinct and overlapping roles for E2F family members in transcription, proliferation and apoptosis. Curr Mol Med 6:739-748.
34. DeGregori J, Kowalik T, Nevins JR. 1995a. Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/ S-regulatory genes. Mol Cell Biol 15:4215-4224.
35. DeGregori J, Leone G, Miron A, Jakoi L, Nevins JR. 1997. Distinct roles for E2F proteins in cell growth control and apoptosis. Proc Natl Acad Sci USA 94:7245-7250.
36. DeGregori J, Leone G, Ohtani K, Miron A, Nevins JR. 1995b. E2F-1 accumulation bypasses a G1 arrest resulting from the inhibition of G1 cyclin-dependent kinase activity. Genes Dev 9:2873-2887.
37. Dessaud E, McMahon AP, Briscoe J. 2008. Pattern formation in the vertebrate neural tube: A sonic hedgehog morphogen-regulated transcriptional network. Development 135:2489-2503.
38. Di Stefano L, Jensen MR, Helin K. 2003. E2F7, a novel E2F featuring DP-independent repression of a subset of E2F-regulated genes. EMBO J 22:6289-6298.
39. Dimova DK, Dyson NJ. 2005. The E2F transcriptional network: Old acquaintances with new faces. Oncogene 24:2810-2826.
40. Donovan SL, Schweers B, Martins R, Johnson D, Dyer MA. 2006. Compensation by tumor suppressor genes during retinal development in mice and humans. BMC Biol 4:14.
41. Dunn JM, Phillips RA, Zhu X, Becker A, Gallie BL. 1989. Mutations in the RB1 gene and their effects on transcription. Mol Cell Biol 9:4596-4604.
42. Dynlacht BD, Moberg K, Lees JA, Harlow E, Zhu L. 1997. Specific regulation of E2F family members by cyclin-dependent kinases. Mol Cell Biol 17:3867-3875.
43. Ferguson KL, McClellan KA, Vanderluit JL, McIntosh WC, Schuurmans C, Polleux F, Slack RS. 2005. A cell-autonomous requirement for the cell cycle regulatory protein, Rb, in neuronal migration. EMBO J 24:4381-4391.
44. Ferguson KL, Vanderluit JL, Hebert JM, McIntosh WC, Tibbo E, MacLaurin JG, Park DS, Wallace VA, Vooijs M, McConnell SK, Slack RS. 2002. Telencephalon-specific Rb knockouts reveal enhanced neurogenesis, survival and abnormal cortical development. EMBO J 21:3337-3346.
45. Ferreira R, Magnaghi-Jaulin L, Robin P, Harel-Bellan A, Trouche D. 1998. The three members of the pocket proteins family share the ability to repress E2F activity through recruitment of a histone deacetylase. Proc Natl Acad Sci USA 95:10493-10498.
46. Field SJ, Tsai FY, Kuo F, Zubiaga AM, Kaelin WG Jr, Livingston DM, Orkin SH, Greenberg ME. 1996. E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell 85:549-561.
47. Friend SH, Bernards R, Rogelj S, Weinberg RA, Rapaport JM, Albert DM, Dryja TP. 1986. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 323:643-646.
48. Fueyo J, Gomez-Manzano C, Yung WK, Liu TJ, Alemany R, Bruner JM, Chintala SK, Rao JS, Levin VA, Kyritsis AP. 1998. Suppression of human glioma growth by adenovirus-mediated Rb gene transfer. Neurology 50:1307-1315.
49. Furukawa Y, Iwase S, Kikuchi J, Nakamura M, Yamada H, Matsuda M. 1999. Transcriptional repression of the E2F-1 gene by interferonalpha is mediated through induction of E2F-4/pRB and E2F-4/p130 complexes. Oncogene 18:2003-2014.
50. Gaubatz S, Lindeman GJ, Ishida S, Jakoi L, Nevins JR, Livingston DM, Rempel RE. 2000. E2F4 and E2F5 play an essential role in pocket protein-mediated G1 control. Mol Cell 6:729-735.
51. Ginsberg D, Vairo G, Chittenden T, Xiao ZX, Xu G, Wydner KL, DeCaprio JA, Lawrence JB, Livingston DM. 1994. E2F-4, a new member of the E2F transcription factor family, interacts with p107. Genes Dev 8:2665-2679.
52. Giovanni A, Keramaris E, Morris EJ, Hou ST, O'Hare M, Dyson N, Robertson GS, Slack RS, Park DS. 2000. E2F1 mediates death of Bamyloid-treated cortical neurons in a manner independent of p53 and dependent on Bax and caspase 3. J Biol Chem 275:11553-11560.
53. Gloster A, Wu W, Speelman A, Weiss S, Causing C, Pozniak C, Reynolds B, Chang E, Toma JG, Miller FD. 1994. The Ta 1 a-tubulin promoter specifies gene expression as a function of neuronal growth and regeneration in transgenic mice. J Neurosci 14:7319-7330.
54. Guillemot F. 2007. Spatial and temporal specification of neural fates by transcription factor codes. Development 134:3771-3780.
55. Hannon GJ, Demetrick D, Beach D. 1993. Isolation of the Rb-related p130 through its interaction with CDK2 and cyclins. Genes Dev A 7:2378-2391.
56. Helin K, Harlow E, Fattaey A. 1993. Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein. Mol Cell Biol 13:6501-6508.
57. Herrup K, Yang Y. 2007. Cell cycle regulation in the postmitotic neuron: Oxymoron or new biology? Nat Rev Neurosci 8:368-378.
58. Hijmans EM, Voorhoeve PM, Beijersbergen RL, van't Veer LJ, Bernards R. 1995. E2F-5, a new E2F family member that interacts with p130 in vivo. Mol Cell Biol 15:3082-3089.
59. Hoglinger GU, Breunig JJ, Depboylu C, Rouaux C, Michel PP, Alvarez-Fischer D, Boutillier AL, Degregori J, Oertel WH, Rakic P, Hirsch EC, Hunot S. 2007. The pRb/E2F cell-cycle pathway mediates cell death in Parkinson's disease. Proc Natl Acad Sci USA 104:3585-3590.
60. Hoozemans JJ, Bruckner MK, Rozemuller AJ, Veerhuis R, Eikelenboom P, Arendt T. 2002. Cyclin D1 and cyclin E are co-localized with cyclooxygenase 2 (COX-2) in pyramidal neurons in Alzheimer disease temporal cortex. J Neuropathol Exp Neurol 61:678-688.
61. Hou ST, Callaghan D, Fournier MC, Hill I, Kang L, Massie B, Morley P, Murray C, Rasquinha I, Slack R, MacManus JP. 2000. The transcription factor E2F1 modulates apoptosis of neurons. J Neurochem 75:91-100.
62. Hou ST, Cowan E, Walker T, Ohan N, Dove M, Rasqinha I, MacManus JP. 2001. The transcription factor E2F1 promotes dopamine-evoked neuronal apoptosis by a mechanism independent of transcriptional activation. J Neurochem 78:287-297.
63. Hsiao KM, McMahon SL, Farnham PJ. 1994. Multiple DNA elements are required for the growth regulation of the mouse E2F1 promoter. Genes Dev 8:1526-1537.
64. Hu QJ, Lees JA, Buchkovich KJ, Harlow E. 1992. The retinoblastoma protein physically associates with the human cdc2 kinase. Mol Cell Biol 12:971-980.
65. Huang Z, Tang XM, Cambi F. 2002. Down-regulation of the retinoblastoma protein (rb) is associated with rat oligodendrocyte differentiation. Mol Cell Neurosci 19:250-262.
66. Humbert PO, Rogers C, Ganiatsas S, Landsberg RL, Trimarchi JM, Dandapani S, Brugnara C, Erdman S, Schrenzel M, Bronson RT, Lees JA. 2000. E2F4 is essential for normal erythrocyte maturation and neonatal viability. Mol Cell 6:281-291.
67. Hurford RK Jr, Cobrinik D, Lee MH, Dyson N. 1997. pRB and p107/ p130 are required for the regulated expression of different sets of E2F responsive genes. Genes Dev 11:1447-1463.
68. Iavarone A, Lasorella A. 2006. ID proteins as targets in cancer and tools in neurobiology. Trends Mol Med 12:588-594.
69. Iavarone A, Massague J. 1999. E2F and histone deacetylase mediate transforming growth factor b repression of cdc25A during keratinocyte cell cycle arrest. Mol Cell Biol 19:916-922.
70. Ikeda MA, Jakoi L, Nevins JR. 1996. A unique role for the Rb protein in controlling E2F accumulation during cell growth and differentiation. Proc Natl Acad Sci USA 93:3215-3220.
71. Jacks T, Fazeli A, Schmitt EM, Bronson RT, Goodell MA, Weinberg RA. 1992. Effects of an Rb mutation in the mouse. Nature 359:295-300.
72. Jiang Z, Zacksenhaus E, Gallie BL, Phillips RA. 1997. The retinoblastoma gene family is differentially expressed during embryogenesis. Oncogene 14:1789-1797.
73. Johnson DG, Ohtani K, Nevins JR. 1994. Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression. Genes Dev 8:1514-1525.
74. Johnson DG, Schwarz JK, Cress WD, Nevins JR. 1993. Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature 365:349-352.
75. Jordan-Sciutto KL, Dorsey R, Chalovich EM, Hammond RR, Achim CL. 2003. Expression patterns of retinoblastoma protein in Parkinson disease. J Neuropathol Exp Neurol 62:68-74.
76. Kato J, Matsushime H, Hiebert SW, Ewen ME, Sherr CJ. 1993. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclinD-dependent kinase CDK4.Genes Dev 7:331-342.
77. Kessaris N, Pringle N, Richardson WD. 2008. Specification of CNS glia from neural stem cells in the embryonic neuroepithelium. Philos Trans R Soc Lond B Biol Sci 363:71-85.
78. Knudson AG Jr. 1971. Mutation and cancer: Statistical study of retinoblastoma. Proc Natl Acad Sci USA 68:820-823.
79. Kovesdi I, Reichel R, Nevins JR. 1986. Identification of a cellular transcription factor involved in E1A trans-activation. Cell 45:219-228.
80. Kusek JC, Greene RM, Pisano MM. 2001. Expression of the E2F and retinoblastoma families of proteins during neural differentiation. Brain Res Bull 54:187-198.
81. Lasorella A, Iavarone A. 2006. The protein ENH is a cytoplasmic sequestration factor for Id2 in normal and tumor cells from the nervous system. Proc Natl Acad Sci USA 103:4976-4981.
82. LeCouter JE, Kablar B, Hardy WR, Ying C, Megeney LA, May LL, Rudnicki MA. 1998a. Strain-dependent myeloid hyperplasia, growth deficiency, and accelerated cell cycle in mice lacking the Rb-related p107 gene. Mol Cell Biol 18:7455-7465.
83. LeCouter JE, Kablar B, Whyte PF, Ying C, Rudnicki MA. 1998b. Strain-dependent embryonic lethality in mice lacking the retinoblastoma-related p130 gene. Development 125:4669-4679.
84. Lee EY, Chang CY, Hu N, Wang YC, Lai CC, Herrup K, Lee WH, Bradley A. 1992. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 359:288-294.
85. Lee MH, Williams BO, Mulligan G, Mukai S, Bronson RT, Dyson N, Harlow E, Jacks T. 1996. Targeted disruption of p107: Functional overlap between p107 and Rb. Genes Dev 10:1621-1632.
86. Lee TC, Almeida D, Claros N, Abramson DH, Cobrinik D. 2006. Cell cycle-specific and cell type-specific expression of Rb in the developing human retina. Invest Ophthalmol Vis Sci 47:5590-5598.
87. Lees E, Faha B, Dulic V, Reed SI, Harlow E. 1992. Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner. Genes Dev 6:1874-1885.
88. Lees JA, Saito M, Vidal M, Valentine M, Look T, Harlow E, Dyson N, Helin K. 1993. The retinoblastoma protein binds to a family of E2F transcription factors. Mol Cell Biol 13:7813-7825.
89. Leone G, DeGregori J, Yan Z, Jakoi L, Ishida S, Williams RS, Nevins JR. 1998. E2F3 activity is regulated during the cell cycle and is required for the induction of S phase. Genes Dev 12:2120-2130.
90. Leone G, Nuckolls F, Ishida S, Adams M, Sears R, Jakoi L, Miron A, Nevins JR. 2000. Identification of a novel E2F3 product suggests a mechanism for determining specificity of repression by Rb proteins. Mol Cell Biol 20:3626-3632.
91. Li J, Ran C, Li E, Gordon F, Comstock G, Siddiqui H, Cleghorn W, Chen HZ, Kornacker K, Liu CG, Pandit SK, Khanizadeh M, Weinstein M, Leone G, de Bruin A. 2008. Synergistic function of E2F7 and E2F8 is essential for cell survival and embryonic development. Dev Cell 14:62-75.
92. Li X, Luo Y, Starremans PG, McNamara CA, Pei Y, Zhou J. 2005. Polycystin-1 and polycystin-2 regulate the cell cycle through the helixloop-helix inhibitor Id2. Nat Cell Biol 7:1202-1212.
93. Li Y, Graham C, Lacy S, Duncan AM, Whyte P. 1993. The adenovirus E1A-associated 130-kD protein is encoded by a member of the retinoblastoma gene family and physically interacts with cyclins A, E. Genes Dev A 7:2366-2377.
94. Lindeman GJ, Dagnino L, Gaubatz S, Xu Y, Bronson RT, Warren HB, Livingston DM. 1998. A specific, nonproliferative role for E2F-5 in choroid plexus function revealed by gene targeting. Genes Dev 12:1092-1098.
95. Liu DX, Nath N, Chellappan SP, Greene LA. 2005. Regulation of neuron survival and death by p130 and associated chromatin modifiers. Genes Dev 19:719-732.
96. Love S. 2003. Neuronal expression of cell cycle-related proteins after brain ischaemia in man. Neurosci Lett 353:29-32.
97. Lukas J, Petersen BO, Holm K, Bartek J, Helin K. 1996. Deregulated expression of E2F family members induces S-phase entry and overcomes p16INK4A-mediated growth suppression. Mol Cell Biol 16:1047-1057.
98. Luo RX, Postigo AA, Dean DC. 1998. Rb interacts with histone deacetylase to repress transcription. Cell 92:463-473.
99. Macleod KF, Hu Y, Jacks T. 1996. Loss of Rb activates both p53-dependent and independent cell death pathways in the developing mouse nervous system. EMBO J 15:6178-6188.
100. MacPherson D, Sage J, Crowley D, Trumpp A, Bronson RT, Jacks T. 2003. Conditional mutation of Rb causes cell cycle defects without apoptosis in the central nervous system. Mol Cell Biol 23:1044-1053.
101. MacPherson D, Sage J, Kim T, Ho D, McLaughlin ME, Jacks T. 2004. Cell type-specific effects of Rb deletion in the murine retina. Genes Dev 18:1681-1694.
102. Magnaghi-Jaulin L, Groisman R, Naguibneva I, Robin P, Lorain S, Le Villain JP, Troalen F, Trouche D, Harel-Bellan A. 1998. Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature 391:601-605.
103. Maiti B, Li J, de Bruin A, Gordon F, Timmers C, Opavsky R, Patil K, Tuttle J, Cleghorn W, Leone G. 2005. Cloning and characterization of mouse E2F8, a novel mammalian E2F family member capable of blocking cellular proliferation. J Biol Chem 280:18211-18220.
104. Mann DJ, Jones NC. 1996. E2F-1 but not E2F-4 can overcome p16-induced G1 cell-cycle arrest. Curr Biol 6:474-483.
105. Marino S, Hoogervoorst D, Brandner S, Berns A. 2003. Rb and p107 are required for normal cerebellar development and granule cell survival but not for Purkinje cell persistence. Development 130:3359-3368.
106. Mateyak MK, Obaya AJ, Sedivy JM. 1999. c-Myc regulates cyclin DCdk4 and -Cdk6 activity but affects cell cycle progression at multiple independent points. Mol Cell Biol 19:4672-4683.
107. Mayol X, Garriga J, Grana X. 1995. Cell cycle-dependent phosphorylation of the retinoblastoma-related protein p130. Oncogene 11:801-808.
108. McClellan KA, Ruzhynsky VA, Douda DN, Vanderluit JL, Ferguson KL, Chen D, Bremner R, Park DS, Leone G, Slack RS. 2007. Unique requirement for Rb/E2F3 in neuronal migration: Evidence for cell cycle-independent functions. Mol Cell Biol 27:4825-4843.
109. McLear JA, Garcia-Fresco G, Bhat MA, Van Dyke TA. 2006. In vivo inactivation of pRb, p107 and p130 in murine neuroprogenitor cells leads to major CNS developmental defects and high seizure rates. Mol Cell Neurosci 33:260-273.
110. Miyajima M, Nornes HO, Sato K, Neuman T. 1996. Overexpression of E2F1 in astrocytes leads to neoplastic transformation and changes in expression of retinoblastoma family members. J Neurosci Res 46:108-113.
111. Moberg K, Starz MA, Lees JA. 1996. E2F-4 switches from p130 to p107 and pRB in response to cell cycle reentry. Mol Cell Biol 16:1436-1449.
112. Muller R. 1995. Transcriptional regulation during the mammalian cell cycle. Trends Genet 11:173-178.
113. Murga M, Fernandez-Capetillo O, Field SJ, Moreno B, Borlado LR, Fujiwara Y, Balomenos D, Vicario A, Carrera AC, Orkin SH,others. 2001. Mutation of E2F2 in mice causes enhanced T lymphocyte proliferation, leading to the development of autoimmunity. Immunity 15:959-970.
114. Neuman E, Flemington EK, Sellers WR, Kaelin WG Jr. 1994. Transcription of the E2F-1 gene is rendered cell cycle dependent by E2F DNA-binding sites within its promoter. Mol Cell Biol 14:6607-6615.
115. Nguyen MD, Boudreau M, Kriz J, Couillard-Despres S, Kaplan DR, Julien JP. 2003. Cell cycle regulators in the neuronal death pathway of amyotrophic lateral sclerosis caused by mutant superoxide dismutase 1. J Neurosci 23:2131-2140.
116. Nielsen SJ, Schneider R, Bauer UM, Bannister AJ, Morrison A, O'Carroll D, Firestein R, Cleary M, Jenuwein T, Herrera RE, Kouzarides T. 2001. Rb targets histone H3 methylation and HP1 to promoters. Nature 412:561-565.
117. Nygard M, Wahlstrom GM, Gustafsson MV, Tokumoto YM, Bondesson M. 2003. Hormone-dependent repression of the E2F-1 gene by thyroid hormone receptors. Mol Endocrinol 17:79-92.
118. Okamoto OK, Oba-Shinjo SM, Lopes L, Marie SKN. 2007. Expression of HOXC9 and E2F2 are up-regulated in CD133(1) cells isolated from human astrocytomas and associate with transformation of human astrocytes. Biochim Biophys Acta 1769:437-442.
119. Panteleeva I, Boutillier S, See V, Spiller DG, Rouaux C, Almouzni G, Bailly D, Maison C, Lai HC, Loeffler JP, Boutillier AL. 2007. HP1a guides neuronal fate by timing E2F-targeted genes silencing during terminal differentiation. EMBO J 26:3616-3628.
120. Parr MJ, Manome Y, Tanaka T, Wen P, Kufe DW, Kaelin WG Jr, Fine HA. 1997. Tumor-selective transgene expression in vivo mediated by an E2F-responsive adenoviral vector. Nat Med 3:1145-1149.
121. Persengiev SP, Kondova II, Kilpatrick DL. 1999. E2F4 actively promotes the initiation and maintenance of nerve growth factor-induced cell differentiation. Mol Cell Biol 19:6048-6056.
122. Qian Y, Luckey C, Horton L, Esser M, Templeton DJ. 1992. Biological function of the retinoblastoma protein requires distinct domains for hyperphosphorylation and transcription factor binding. Mol Cell Biol 12:5363-5372.
123. Ranganathan S, Scudiere S, Bowser R. 2001. Hyperphosphorylation of the retinoblastoma gene product and altered subcellular distribution of E2F-1 during Alzheimer's disease and amyotrophic lateral sclerosis. J Alzheimers Dis 3:377-385.
124. Rayman JB, Takahashi Y, Indjeian VB, Dannenberg JH, Catchpole S, Watson RJ, te Riele H, Dynlacht BD. 2002. E2F mediates cell cycledependent transcriptional repression in vivo by recruitment of an HDAC1/mSin3B corepressor complex. Genes Dev 16:933-947.
125. Reichel R, Kovesdi I, Nevins JR. 1987. Developmental control of a promoter-specific factor that is also regulated by the E1A gene product. Cell 48:501-506.
126. Rempel RE, Saenz-Robles MT, Storms R, Morham S, Ishida S, Engel A, Jakoi L, Melhem MF, Pipas JM, Smith C, Nevins JR. 2000. Loss of E2F4 activity leads to abnormal development of multiple cellular lineages. Mol Cell 6:293-306.
127. Ren B, Cam H, Takahashi Y, Volkert T, Terragni J, Young RA, Dynlacht BD. 2002. E2F integrates cell cycle progression with DNA repair, replication, and G2/M checkpoints. Genes Dev 16:245-256.
128. Rich JN, Guo C, McLendon RE, Bigner DD, Wang XF, Counter CM. 2001. A genetically tractable model of human glioma formation. Cancer Res 61:3556-3560.
129. Richter S, Vandezande K, Chen N, Zhang K, Sutherland J, Anderson J, Han L, Panton R, Branco P, Gallie B. 2003. Sensitive and efficient detection of RB1 gene mutations enhances care for families with retinoblastoma. Am J Hum Genet 72:253-269.
130. Robanus-Maandag E, Dekker M, van der Valk M, Carrozza ML, Jeanny JC, Dannenberg JH, Berns A, te Riele H. 1998. p107 is a suppressor of retinoblastoma development in pRb-deficient mice. Genes Dev 12:1599-1609.
131. Ross SE, Greenberg ME, Stiles CD. 2003. Basic helix-loop-helix factors in cortical development. Neuron 39:13-25.
132. Ruzhynsky VA, McClellan KA, Vanderluit JL, Jeong Y, Furimsky M, Park DS, Epstein DJ, Wallace VA, Slack RS. 2007. Cell cycle regulator E2F4 is essential for the development of the ventral telencephalon. J Neurosci 27:5926-5935.
133. Saavedra HI, Wu L, de Bruin A, Timmers C, Rosol TJ, Weinstein M, Robinson ML, Leone G. 2002. Specificity of E2F1, E2F2, and E2F3 in mediating phenotypes induced by loss of Rb. Cell Growth Differ 13:215-225.
134. Sardet C, Vidal M, Cobrinik D, Geng Y, Onufryk C, Chen A, Weinberg RA. 1995. E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle. Proc Natl Acad Sci USA 92:2403-2407.
135. Schwarz JK, Bassing CH, Kovesdi I, Datto MB, Blazing M, George S, Wang XF, Nevins JR. 1995. Expression of the E2F1 transcription factor overcomes type beta transforming growth factor-mediated growth suppression. Proc Natl Acad Sci USA 92:483-487.
136. Sears R, Ohtani K, Nevins JR. 1997. Identification of positively and negatively acting elements regulating expression of the E2F2 gene in response to cell growth signals. Mol Cell Biol 17:5227-5235.
137. Sherr CJ, Roberts JM. 1999. CDK inhibitors: Positive and negative regulators of G1-phase progression. Genes Dev 13:1501-1512.
138. Sherr CJ, Roberts JM. 2004. Living with or without cyclins and cyclindependent kinases. Genes Dev 18:2699-2711.
139. Slack RS, El-Bizri H, Wong J, Belliveau DJ, Miller FD. 1998. A critical temporal requirement for the retinoblastoma protein family during neuronal determination. J Cell Biol 140:1497-1509.
140. Slack RS, Hamel PA, Bladon TS, Gill RM, McBurney MW. 1993. Regulated expression of the retinoblastoma gene in differentiating embryonal carcinoma cells. Oncogene 8:1585-1591.
141. Smith EJ, Leone G, Nevins JR. 1998. Distinct mechanisms control the accumulation of the Rb-related p107 and p130 proteins during cell growth. Cell Growth Differ 9:297-303.
142. Storre J, Elsasser HP, Fuchs M, Ullmann D, Livingston DM, Gaubatz S. 2002. Homeotic transformations of the axial skeleton that accompany a targeted deletion of E2f6. EMBO Rep 3:695-700.
143. Suzuki-Takahashi I, Kitagawa M, Saijo M, Higashi H, Ogino H, Matsumoto H, Taya Y, Nishimura S, Okuyama A. 1995. The interactions of E2F with pRB and with p107 are regulated via the phosphorylation of pRB and p107 by a cyclin-dependent kinase. Oncogene 10:1691-1698.
144. Swetloff A, Ferretti P. 2005. Changes in E2F5 intracellular localization in mouse and human choroid plexus epithelium with development. Int J Dev Biol 49:859-865.
145. Takahashi Y, Rayman JB, Dynlacht BD. 2000. Analysis of promoter binding by the E2F and pRB families in vivo: Distinct E2F proteins mediate activation and repression. Genes Dev 14:804-816.
146. Tallquist MD, Soriano P. 2000. Epiblast-restricted Cre expression in MORE mice: A tool to distinguish embryonic vs. extra-embryonic gene function. Genesis 26:113-115.
147. Tommasi S, Pfeifer GP. 1995. In vivo structure of the human cdc2 promoter: Release of a p130-E2F-4 complex from sequences immediately upstream of the transcription initiation site coincides with induction of cdc2 expression. Mol Cell Biol 15:6901-6913.
148. Trimarchi JM, Fairchild B, Verona R, Moberg K, Andon N, Lees JA. 1998. E2F-6, a member of the E2F family that can behave as a transcriptional repressor. Proc Natl Acad Sci USA 95:2850-2855.
149. Trimarchi JM, Fairchild B, Wen J, Lees JA. 2001. The E2F6 transcription factor is a component of the mammalian Bmi1-containing polycomb complex. Proc Natl Acad Sci USA 98:1519-1524.
150. Trimarchi JM, Lees JA. 2002. Sibling rivalry in the E2F family. Nat Rev Mol Cell Biol 3:11-20.
151. Trouche D, Cook A, Kouzarides T. 1996. The CBP co-activator stimulates E2F1/DP1 activity. Nucleic Acids Res 24:4139-4145.
152. Tsai KY, Hu Y, Macleod KF, Crowley D, Yamasaki L, Jacks T. 1998. Mutation of E2f-1 suppresses apoptosis and inappropriate S phase entry and extends survival of Rb-deficient mouse embryos. Mol Cell 2:293-304.
153. Tsai SY, Opavsky R, Sharma N, Wu L, Naidu S, Nolan E, Feria-Arias E, Timmers C, Opavska J, de Bruin A, Chong JL, Trikha P, Fernandez SA, Stromberg P, Rogol TJ, Leone G. 2008. Mouse development with a single E2F activator. Nature 454:1137-1141.
154. Vairo G, Livingston DM, Ginsberg D. 1995. Functional interaction between E2F-4 and p130: Evidence for distinct mechanisms underlying growth suppression by different retinoblastoma protein family members. Genes Dev 9:869-881.
155. van den Heuvel S, Dyson NJ. 2008. Conserved functions of the pRB and E2F families. Nat Rev Mol Cell Biol 9:713-724.
156. Vanderluit JL, Ferguson KL, Nikoletopoulou V, Parker M, Ruzhynsky V, Alexson T, McNamara SM, Park DS, Rudnicki M, Slack RS. 2004. p107 regulates neural precursor cells in the mammalian brain. J Cell Biol 166:853-863.
157. Vanderluit JL, Wylie CA, McClellan KA, Ghanem N, Fortin A, Callaghan S, MacLaurin JG, Park DS, Slack RS. 2007. The Retinoblastoma family member p107 regulates the rate of progenitor commitment to a neuronal fate. J Cell Biol 178:129-139.
158. Vincent I, Rosado M, Davies P. 1996. Mitotic mechanisms in Alzheimer's disease? J Cell Biol 132:413-425.
159. Vooijs M, te Riele H, van der Valk M, Berns A. 2002. Tumor formation in mice with somatic inactivation of the retinoblastoma gene in interphotoreceptor retinol binding protein-expressing cells. Oncogene 21: 4635-4645.
160. Wang L, Wang R, Herrup K. 2007. E2F1 works as a cell cycle suppressor in mature neurons. J Neurosci 27:12555-12564.
161. Wells J, Boyd KE, Fry CJ, Bartley SM, Farnham PJ. 2000. Target gene specificity of E2F and pocket protein family members in living cells. Mol Cell Biol 20:5797-5807.
162. Winston JT, Coats SR, Wang YZ, Pledger WJ. 1996. Regulation of the cell cycle machinery by oncogenic ras. Oncogene 12:127-134.
163. Woo MS, Sanchez I, Dynlacht BD. 1997. p130 and p107 use a conserved domain to inhibit cellular cyclin-dependent kinase activity. Mol Cell Biol 17:3566-3579.
164. Wu L, de Bruin A, Saavedra HI, Starovic M, Trimboli A, Yang Y, Opavska J, Wilson P, Thompson JC, Ostrowski MC, Rosol TJ, Woollett LA, Weinstein M, Cross JC, Robinson ML, Leone G. 2003. Extra-embryonic function of Rb is essential for embryonic development and viability. Nature 421:942-947.
165. Wu L, Timmers C, Maiti B, Saavedra HI, Sang L, Chong GT, Nuckolls F, Giangrande P, Wright FA, Field SJ, Greenberg ME, Orkin S, Nevins JR, Robinson ML, Leone G. 2001. The E2F1-3 transcription factors are essential for cellular proliferation. Nature 414: 457-462.
166. Xiao ZX, Ginsberg D, Ewen M, Livingston DM. 1996. Regulation of the retinoblastoma protein-related protein p107 by G1 cyclin-associated kinases. Proc Natl Acad Sci USA 93:4633-4637.
167. Xu X, Bieda M, Jin VX, Rabinovich A, Oberley MJ, Green R, Farnham PJ. 2007. A comprehensive ChIP-chip analysis of E2F1, E2F4, and E2F6 in normal and tumor cells reveals interchangeable roles of E2F family members. Genome Res 17:1550-1561.
168. Yamasaki L, Jacks T, Bronson R, Goillot E, Harlow E, Dyson NJ. 1996. Tumor induction and tissue atrophy in mice lacking E2F-1. Cell 85:537-548.
169. Yang Y, Geldmacher DS, Herrup K. 2001. DNA replication precedes neuronal cell death in Alzheimer's disease. J Neurosci 21:2661-2668.
170. Yee AS, Reichel R, Kovesdi I, Nevins JR. 1987. Promoter interaction of the E1A-inducible factor E2F and its potential role in the formation of a multi-component complex. EMBO J 6:2061-2068.
171. Zalmas LP, Zhao X, Graham AL, Fisher R, Reilly C, Coutts AS, La Thangue NB. 2008. DNA-damage response control of E2F7 and E2F8. EMBO Rep 9:252-259.
172. Zebedee Z, Hara E. 2001. Id proteins in cell cycle control and cellular senescence. Oncogene 20:8317-8325.
173. Zhang J, Gray J, Wu L, Leone G, Rowan S, Cepko CL, Zhu X, Craft CM, Dyer MA. 2004. Rb regulates proliferation and rod photoreceptor development in the mouse retina. Nat Genet 36:351-360.
174. Zhu L, Harlow E, Dynlacht BD. 1995a. p107 uses a p21CIP1-related domain to bind cyclin/cdk2 and regulate interactions with E2F. Genes Dev 9:1740-1752.
175. Zhu L, Zhu L, Xie E, Chang LS. 1995b. Differential roles of two tandem E2F sites in repression of the human p107 promoter by retinoblastoma and p107 proteins. Mol Cell Biol 15:3552-3562.
176. Ziebold U, Reza T, Caron A, Lees JA. 2001. E2F3 contributes both to the inappropriate proliferation and to the apoptosis arising in Rb mutant embryos. Genes Dev 15:386-391.